ICYMI, this week we had stories on the latest coverage from the 2022 American Academy of Dermatology Annual meeting, our newest drug pipeline video and more.
A SOC scientific symposium iPoster posited that using self-learning modules to bridge the gap in skin of color dermatology knowledge could be helpful in a medical education curriculum.
The company announced the results from its long-term extension study, highlighting improved efficacy outcomes, quality of life, and tolerability data.
A poster presented at AAD 2022 dives into one of the largest barriers in obtaining gender-affirming neurotoxin and filler treatment for patients—the cost.
Determining the cause of a child's rash is important to proper diagnosis and management. Allergic contact dermatitis and eczema are 2 of most common causes.
Dermatologists continue to be split on the pros and cons of skin cancer screening, from overdiagnosis to early detection of thin melanomas.
In this video interview, Christopher Bunick, MD, PhD dives into the topic of congenital ichthyosis describing his talk on the skin condition at the American Academy of Dermatology 2022 Annual Meeting.
In their session, “Translating Evidence into Practice: Atopic Dermatitis Guidelines,” at the current AAD annual meeting, Jonathan I. Silverberg, MD, PhD, MPH, FAAD, Peter A. Lio, MD, FAAD, Andrew Blauvelt, MD, FAAD, and Robert Sidbury, MD, MPH, FAAD, discuss updates in new therapies, clinical pearls, and potential co-morbidities.
A look at the way that skin may react to COVID-19 and the vaccine for the disease.
In this video interview, we sit down with both Jennifer Lin Hsiao, MD, FAAD, and Scott Worswick, MD, FAAD, to talk in detail about their presentation, "Hidradenitis Suppurativa and Pityriasis Rubra Pilaris: Updates on Treatments for Two Conditions that are Difficult to Manage."
Master the dialogue about food and skin, hair and nail health.
Zoe Diana Draelos, MD, FAAD, explains the method of using the color wheel to guide your patients nutrition to help skin, nails, and more.
Experts explored out-of-the-box solutions for treating challenging skin and hair disorders at the American Academy of Dermatology (AAD)’s 2022 Annual Meeting held March 25 to 29, 2022, in Boston, Massachusetts.
Anne M Chapas, MD, FAAD, discusses what to do when cosmetic procedures go wrong during a presentation at the AAD 2022 annual meeting.
An expert debunks the myths surrounding sun-related factors associated with melanoma in a presentation at the 2022 American Academy of Dermatology Annual Meeting.
In this video interview, Adam J. Friedman, MD, FAAD, gives the highlights from his presentation at the 2022 American Academy of Dermatology annual meeting about dietary triggers in acne, providing evidence, and discussing how the idea came to be.
Experts detailed current evidence-based treatment guidelines for Merkel cell carcinoma at the 2022 American Academy of Dermatology (AAD)’s Annual meeting held March 25 to 29, 2022, in Boston, Massachusetts.
Patients on testosterone for masculinizing hormone therapy are at an increased risk of acne due to both inside and outside factors. Matthew David Mansh, MD, FAAD, explains his process for treating these patients.
Incoming president Mark D Kaufmann, MD, FAAD, outlined his action plan for the specialty’s rapidly changing landscape in his plenary session speech at the American Academy of Dermatology 2022 Annual Meeting held March 25 to 29, 2022, in Boston, Massachusetts.
Nail disorders such as brittle nails and pincer nails commonly lead patients to seek dermatologic consultation, with each case presenting a particular set of therapeutic challenges for both clinician and patient. A more in-depth understanding of the physiology, biomechanics, and precipitating factors of these disease processes can optimize treatment and management decisions.
Vitiligo is challenging to treat; fortunately, continued research has led to improvements and refinements in options, giving much-needed hope to patients with this skin condition.
Clascoterone cream 1% phase 3 results presented at meeting.
New data shows complete skin clearance using bimekizumab in moderate to severe plaque psoriasis open-label extension study.
In this video interview, Peter A. Lio, MD, FAAD , discusses his presentation about pain-free dermatology at the 2022 American Academy of Dermatology annual meeting. We talk strategies, benefits, and more.
Learning vocabulary to advocate for equity, and provide actionable tools for nurse practitioners to confront and dismantle health disparities was this keynote speaker's topic at the 43rd National Conference on Pediatric Health Care in Dallas, Texas.
CBD is still a gray area for many pharmacists and health care providers.
This week's edition of the Mainstream Patients features stories about skin of color dermatology, a deep dive on hair loss, and more.
Once synonymous with puberty, acne is a growing concern for adults—particularly for women—from the 20s to well into their 40s. Christopher Bunick, MD, PhD delved into treatment options for this increasing patient population at the American Academy of Dermatology 2022 Annual Meeting.
Evidence suggests a second booster improve protection against severe COVID.
Understanding gender terms and addressing patients using the right pronouns is vital to decreasing health disparities in the LGBQT community.
In her presentation at the recent American Academy of Dermatology (AAD) Annual Meeting, Anisha Patel, MD, FAAD, discusses challenging oncodermatology cases at the MD Anderson Cancer Center, University of Texas Health Science Center.
Creating a heterogenous cohort in pediatric clinical trials aids in the generalizing of the results and helps ensure that data of efficacy and safety are more accurate. A report looks at data from the past 10 years to see how often race/ethnicity are reported and whether there has been improved inclusion of non-White children.
Social media can be a great way to expand exposure for a practice or physician; however, there are many dos-and-don’ts to understand when signing up for a social platform.
In this week’s Pointers with Dr Portela, the 208SkinDoc answers the question, “Should I be taking a collagen supplement?” He breaks down the evidence as the answer is not as simple as it may seem.
In this first part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, explains the science behind her presentation on "The Utility of Circulating Tumor DNA for Detecting Clinically Evident and Occult Merkel Cell Carcinoma." This was presented at the 2022 American Academy of Dermatology Annual Meeting.
Christopher Bunick, MD, PhD, offered pointers on how to address the physical and mental aspects of this complex disease in this exclusive interview in conjunction with the American Academy of Dermatology 2022 Annual Meeting.
In his presentation at the recent AAD, Neil Sadick, MD, FACP, FAACS, FACph, FAAD, highlighted new cosmeceutical concepts for the body, including the whole-body rejuvenation program and AM/PM approach.
What’s new in body skin care? According to Neil Sadick, MD, FACP, FAACS, FACph, FAAD, all fingers point to these methods.
In a presentation at the recent AAD annual meeting, Diane M. Thiboutot, MD, discusses the potential risks of antibiotic resistance in acne management.
Klint Peebles, MD, FAAD, breaks down the core terminology for LGBTQ/SGD individuals so all patients can feel understood when entering the exam room.
The company’s combined the need for science advancement with a booth that kept people coming back.
The company announced its collaboration with the American Academy of Dermatology on, “Pathways: Inclusivity in Dermatology,” to increase the number of practicing dermatologists in the Black, Latino, and Indigenous communities in medicine over the next 5 years.
Each month, Dermatology Times® features a roundup of products trending in skin care. Click here to find out what products are trending for the month of March.
In this second part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, explains the data behind the clinical trials on using circulating tumor DNA for merkel cell carcinoma (MCC). She expands on her talk from the 2022 American Academy of Dermatology Annual Meeting.
Andrew Blauvelt, MD, MBA, reviews recent advances in the therapeutic landscape for moderate to severe atopic dermatitis.
In her presentation at the recent American Academy of Dermatology Annual Meeting, Peggy A. Wu, MD, MPH, discussed the most common causes for systemic contact dermatitis, and how diet may play a significant role.
Dr Andrew Blauvelt reviews key highlights and clinical implications from the LIBERTY AD OLE study assessing the effect of long-term dupilumab treatment on efficacy improvements in adults with moderate to severe atopic dermatitis.
In this third part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, highlights the in practice experiences in using circulating tumor DNA for merkel cell carcinoma (MCC).
A poster from the 2022 American Academy of Dermatology Annual Meeting presented subgroup analyses from the Effisayil 1 study that showed the efficacy of spesolimab was consistent across all prespecified patient populations, including those with or without IL-36RN mutations.
In this drug pipeline video, Pearl Grimes, MD, FAAD, and Seemal R. Desai, MD, FAAD discuss what's currently happening in the vitiligo pipeline including why current treatments are lacking, what's coming soon, and what it may cost.
VisualDX uses diverse imagery to help increase knowledge of disease manifestations in a range of skin types.
In this fourth part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, talks about what to look forward to in treatment and clinical trials of merkel cell carcinoma (MCC).
A poster from the 2022 American Academy of Dermatology Annual Meeting gathered the real-world data around patients using dupilumab to treat atopic dermatitis.